PriceTargets.com logo

LON:RWS - RWS Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: GBX 658.20
  • Forecasted Upside: 7.37 %
  • Number of Analysts: 5
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 4 Buy Ratings
  • 0 Strong Buy Ratings
GBX 613 As of 03/4/2021 05:36 PM ET
▼ -7 (-1.13%)
1 month | 3 months | 12 months
Get New RWS Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for RWS and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for RWS

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
GBX 658.20
▲ +7.37% Upside Potential
This price target is based on 5 analysts offering 12 month price targets for RWS in the last 3 months. The average price target is GBX 658.20, with a high forecast of GBX 761 and a low forecast of GBX 530. The average price target represents a 7.37% upside from the last price of GBX 613.
Buy
The current consensus among 5 investment analysts is to buy stock in RWS. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
9/10/2019
  • 0 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
12/9/2019
  • 0 strong buy ratings
  • 3 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
3/8/2020
  • 0 strong buy ratings
  • 3 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
6/6/2020
  • 0 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
9/4/2020
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
12/3/2020
  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
2/1/2021
  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
3/3/2021

Latest Recommendations

  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 0 sell ratings

DateBrokerageActionRatingPrice TargetDetails
2/1/2021Canaccord GenuityInitiated CoverageBuyGBX 690
i
1/19/2021Jefferies Financial GroupReiterated RatingBuyGBX 761
i
9/1/2020BarclaysReiterated RatingOverweightGBX 610
i
7/3/2020Berenberg BankReiterated RatingBuy
i
6/10/2020BarclaysLower Price TargetOverweightGBX 630 ➝ GBX 610
i
6/9/2020Berenberg BankBoost Price TargetBuyGBX 650 ➝ GBX 700
i
4/24/2020HSBCLower Price TargetHoldGBX 600 ➝ GBX 530
i
1/13/2020HSBCReiterated RatingHold
i
12/18/2019BarclaysBoost Price TargetOverweightGBX 615 ➝ GBX 630
i
12/10/2019Berenberg BankBoost Price TargetBuyGBX 670 ➝ GBX 740
i
10/16/2019Deutsche Bank AktiengesellschaftReiterated RatingOverweightGBX 615
i
10/16/2019BarclaysBoost Price TargetOverweightGBX 610 ➝ GBX 615
i
10/4/2019Berenberg BankReiterated RatingBuy
i
6/12/2019BarclaysBoost Price TargetOverweightGBX 560 ➝ GBX 610
i
6/11/2019Berenberg BankBoost Price TargetBuyGBX 615 ➝ GBX 670
i
6/6/2019Numis SecuritiesDowngradeAddGBX 450 ➝ GBX 600
i
4/18/2019Berenberg BankBoost Price TargetBuyGBX 530 ➝ GBX 615
i
1/18/2019BarclaysInitiated CoverageOverweightGBX 560
i
10/10/2018Numis SecuritiesDowngradeAddGBX 510
i
6/22/2018Berenberg BankReiterated RatingBuyGBX 530
i
6/7/2018Shore CapitalReiterated RatingHold
i
6/7/2018Numis SecuritiesUpgradeBuyGBX 490 ➝ GBX 450
i
4/24/2018Numis SecuritiesReiterated RatingAddGBX 490
i
4/24/2018Shore CapitalReiterated RatingHoldGBX 459
i
3/28/2018Berenberg BankReiterated RatingBuyGBX 530
i
2/13/2018Numis SecuritiesReiterated RatingAddGBX 490
i
12/7/2017Berenberg BankReiterated RatingBuyGBX 530
i
12/6/2017Numis SecuritiesUpgradeAddGBX 490
i
12/6/2017Shore CapitalReiterated RatingHold
i
11/29/2017Berenberg BankInitiated CoverageBuyGBX 530
i
10/19/2017Numis SecuritiesBoost Price TargetHoldGBX 430 ➝ GBX 490
i
10/18/2017Shore CapitalReiterated RatingHold
i
10/8/2017Numis SecuritiesBoost Price TargetHoldGBX 375 ➝ GBX 430
i
10/2/2017Numis SecuritiesReiterated RatingHoldGBX 375
i
10/2/2017Shore CapitalReiterated RatingHold
i
8/10/2017Shore CapitalReiterated RatingHold
i
8/3/2017Shore CapitalDowngradeHold
i
7/6/2017CitigroupInitiated CoverageNeutralGBX 395
i
6/20/2017Shore CapitalReiterated RatingBuy
i
4/12/2017Numis SecuritiesReiterated RatingAddGBX 375
i
4/12/2017Shore CapitalReiterated RatingBuy
i
2/14/2017Numis SecuritiesReiterated RatingAddGBX 375
i
2/14/2017Shore CapitalReiterated RatingBuy
i
12/6/2016Numis SecuritiesReiterated RatingAddGBX 335
i
10/11/2016Numis SecuritiesBoost Price TargetAddGBX 255 ➝ GBX 295
i
6/7/2016Numis SecuritiesReiterated RatingAddGBX 255
i
4/12/2016Numis SecuritiesDowngradeAddGBX 230 ➝ GBX 255
i
(Data available from 3/4/2016 forward)
RWS logo
RWS Holdings plc engages in the translation, intellectual property (IP) support, life sciences language, and localization businesses. The company operates through IP Services, Life Sciences, and Moravia segments. The IP Services segment provides patent translation and filing solutions, as well as IP search services. The Life Sciences segment offers a full suite of language services, including language solutions for clinical trial management; linguistic validation of clinical outcomes assessments; and regulatory affairs expertise, medical device documentation, and marketing and communications services, as well as e-learning and training programs for the life sciences industry. The Moravia segment provide localized products and content to consumers. It serves automotive, energy, retail and e-commerce, legal, travel and hospitality, banking and finance, industrial and manufacturing, life sciences, technology, chemical, media and entertainment, and telecommunication sectors. The company primarily operates in the United Kingdom, the United States, Continental Europe, China, Japan, India, Thailand, Argentina, Australia, Columbia, and Canada. RWS Holdings plc was founded in 1958 and is headquartered in Chalfont St Peter, the United Kingdom.
Read More

Today's Range

Now: GBX 613
603
621

50 Day Range

MA: GBX 595.58
523
640

52 Week Range

Now: GBX 613
399.71
767

Volume

990,014 shs

Average Volume

1,604,377 shs

Market Capitalization

£2.38 billion

P/E Ratio

36.27

Dividend Yield

1.45%

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of RWS?

The following Wall Street analysts have issued research reports on RWS in the last twelve months: Barclays PLC, Berenberg Bank, Canaccord Genuity, HSBC Holdings plc, and Jefferies Financial Group Inc..
View the latest analyst ratings for RWS.

What is the current price target for RWS?

5 Wall Street analysts have set twelve-month price targets for RWS in the last year. Their average twelve-month price target is GBX 658.20, suggesting a possible upside of 7.4%. Jefferies Financial Group Inc. has the highest price target set, predicting RWS will reach GBX 761 in the next twelve months. HSBC Holdings plc has the lowest price target set, forecasting a price of GBX 530 for RWS in the next year.
View the latest price targets for RWS.

What is the current consensus analyst rating for RWS?

RWS currently has 1 hold rating and 4 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe RWS will outperform the market and that investors should add to their positions of RWS.
View the latest ratings for RWS.

What other companies compete with RWS?

Other companies that are similar to RWS include Rentokil Initial plc (RTO.L), Intertek Group, Ritchie Bros. Auctioneers, IWG, HomeServe, Keywords Studios, BCA Marketplace, Serco Group plc (SRP.L), GlobalData, GDI Integrated Facility Services, Energy Fuels, Smart Metering Systems plc (SMS.L), Mitie Group, Capita and Johnson Service Group PLC (JSG.L).

How do I contact RWS's investor relations team?

RWS's physical mailing address is Europa House Chiltern Park, Chiltern Hill, GERRARDS CROSS, SL9 9FG, United Kingdom. The company's listed phone number is +44-1753-480200. The official website for RWS is www.rws.com.